SLU-PP-332 100mg x30 Capsules
Standard-Dose SLU-PP-332 Capsules for ERR Research
SLU-PP-332 at the standard 100mg dose in 30-capsule format for comprehensive pan-ERR research and exercise mimetic protocol studies.
Standard-Dose SLU-PP-332 Capsules for ERR Research
Standard research dose capsules enabling complete ERR agonism protocol studies at the dose used in published preclinical research.
As one of the most studied compounds in the metabolic & fat loss research space, SLU-PP-332 has attracted sustained scientific interest across Standard ERR research protocols, Exercise mimetic studies. Peer-reviewed evidence indicates that standard 100mg research dose, which has positioned SLU-PP-332 as a reference standard for researchers exploring standard err research protocols outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
SLU-PP-332 Documented Benefits: 1 Documented Mechanisms
Research-Standard Dose
Matches doses used in published SLU-PP-332 preclinical endurance and metabolic studies.
How SLU-PP-332 Works: Molecular Mechanism & Pathway
Same pan-ERR nuclear receptor agonism mechanism at standard research dose.
The 1 primary research pathways identified for SLU-PP-332 — Research-Standard Dose — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that 30 capsule supply, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, SLU-PP-332's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
SLU-PP-332 is routinely studied alongside AICAR and SLU-PP-332 in metabolic & fat loss-focused compound panels. Researchers investigating standard err research protocols have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that 99%+ purity has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All SLU-PP-332 research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Standard 100mg research dose
- 30 capsule supply
- 99%+ purity
Ideal For
- Standard ERR research protocols
- Exercise mimetic studies
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on SLU-PP-332. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Standard 100mg research dose
30 capsule supply
99%+ purity
Third-Party Verified Every Batch
Each vial of SLU-PP-332 is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
